Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Insilico Medicine
Pharma
Takeda, Daiichi, Samsung Bio and more—Fierce Pharma Asia
Takeda's R&D chief Andy Plump will retire. Daiichi Sankyo beat back a $1.3 billion damage claim. Samsung Biologics signed a $262 million contract.
Angus Liu
Sep 11, 2026 9:15am
GSK-Hansoh, Merck-Kelun, AZ-Dizal—Fierce Pharma Asia
Jul 17, 2026 9:38am
Bora inks $2.5B deal with drug discovery AI specialist Insilico
Jul 15, 2026 7:08am
AZ's China deals, Kailera-Hengrui—Fierce Pharma Asia
Jul 10, 2026 8:51am
Solid tumor CAR-T, Pfizer-Innovent, China deals—Fierce Pharma Asia
Jun 26, 2026 8:51am
Drug tariffs, Takeda, Lilly-Insilico—Fierce Pharma Asia
Apr 3, 2026 7:49am
